|
What they said about 2004
“Excellent platform for networking and information exchange on latest stage of science based manufacturing, regulatory and business issues”
Rolf Werner, Corporate Director, Corporate Division Biopharmaceuticals, Boehringer Ingelheim
“Very high quality”
Glenn Brame, Site Head, Baxter BioScience
“Good representation of high-level decision makers in biotech industry”
Aline Seilly, European technology manager, Millipore France
“Good networking, well organised, interesting”
Frans Hoeks, Director, Product Management, Lonza
“Well worth the time invested, I learned a lot”
John Barnes, Manufacturing Site Director, GlaxoSmithKline
“Very informative on current biomanufacturing processes, provided a useful overview of future trends; good environment for networking”
Christiane Piselli, Senior Consultant, Piselli Consulting S.L.
“Very good opportunities for networking. Very good service/responsiveness by Terrapinn”
Dr Bernd Kruger, European Sales and marketing Manager, Sigma-Aldrich
“True reflection of the current market driving forces. Provided insight into the future of the biopharmaceutical community and the implication of the business drivers on Biotech companies who need to continuously maintain their competitive advantage to ensure success.”
Dr Rachel Jarman-Smith, European Technical Manager, JRH Biosciences
“Very good overview of upper end of the market. Relevant companies well represented. Technical info good.”
Winston Leukes, CSO, Synexa Life Sciences
“The event was great, the most concentrated biotech individuals brought together in one event. The right management attending the event give it a good balance”
Robert Dream, Director, Europe, Lockwood Greene
“Another well-done conference, keep up the quality and maintain the selective comfortable size”
Barry Holtz, President, CEO, Inflexion Therapeutics
|
